Aortic coarctation epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Robot: Changing Category:Disease state to Category:Disease)
Line 25: Line 25:
==References==
==References==
{{reflist|2}}
{{reflist|2}}
{{WH}}
{{WS}}


[[Category:Cardiology]]
[[Category:Cardiology]]
[[Category:Pediatrics]]
[[Category:Pediatrics]]
[[Category:Disease state]]
[[Category:Disease]]
[[Category:Congenital heart disease]]
[[Category:Congenital heart disease]]
{{WH}}
{{WS}}

Revision as of 19:00, 9 December 2011

Aortic coarctation Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Aortic Coarctation from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Electrocardiogram

Chest X-Ray

CT

MRI

Angiography

Echocardiography

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Aortic coarctation epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Aortic coarctation epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Aortic coarctation epidemiology and demographics

CDC on Aortic coarctation epidemiology and demographics

Aortic coarctation epidemiology and demographics in the news

Blogs on Aortic coarctation epidemiology and demographics

Directions to Hospitals Treating Aortic coarctation

Risk calculators and risk factors for Aortic coarctation epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Overview

Coarctation occurs in about 7% of patients with congenital heart defects. It is more common in males than females with a ratio of 2:1. Up to 25% of patients with Turner syndrome have coarctation of the aorta.

Epidemiology and demographics

Aortic coarctation is a common congenital heart defect. While statistics vary across research, aortic coarctation occurs in approximately 6-10% of all congenital heart disease cases. In live births, aortic coarctation accounts for approximately 5-7% of congenital heart disease in severely ill infants.

The mortality rate of aortic coarctation hinges primarily on the age of surgical intervention to repair the defect. Left untreated, less than 20% of untreated patients reach the age of 50. However, with surgical repair, mortality rates are far less severe. If repaired by the age of 14, the mortality rate for 20 years out post-surgery is 9% (a 91% survival rate). If repaired later than 14, the mortality rate is 11% (a 79% survival rate).

In expectant mothers with a coarctation of the aorta, the maternal mortaliy rate ranges between 3-8%. Even with repair, there is a risk of developing complications during pregnancy.

Demographically, aortic coarctation has a certain link to specific races. Aortic coarctation is more common in Caucasians, with approximately 7 times more cases in Caucasians versus Asian. The incidence has also been noted, in some populations, to be lower in Native American races than Caucasians. It is more common in males than females with a ratio of 2:1 and a prevalence of 2-5 times occurring more frequently in males than females. Aortic coarctation, like many congenital heart diseases, is more common in patients with other genetic conditions. As many as 10-25% of patients with Turner syndrome have an accompanying coarctation of the aorta.

Other accompanying conditions, that increase the likelihood of a coarctation of the aorta, include:

References

Template:WH

Template:WS